The Filing Desk

Acme United

ACU · NYSE · Industrials · Financials, fiscal 2016 to 2025

ACU · Last close · November 19, 2026
$67.15
Value Acme United yourself

Acme United's revenue rose 1.1% to $196 million in fiscal 2025. Its operating margin was 7.5%, up from 7.3% a year earlier. Free cash flow was $8 million, up 57.0%. It paid out $2 million in dividends and buybacks, 31% of free cash flow. The diluted share count fell 0.3%.

ACME UNITED CORP Latest fiscal year ended December 31, 2025 10-K filed March 11, 2026 · 0001193125-26-102079 Updated
Revenue
$196M
1.1%
Operating margin
7.5%
0.2 pts
Net income
$10M
1.6%
Free cash flow
$8M
57.0%
Return on capital
9.4%
0.9 pts
Market cap
$289M
Nov 19 close
P/E
24.7x
On $2.72 EPS, 4 qtrs

Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.

Charts show fiscal years, from the 10-K filings.

What Acme United does

Acme United makes and sells first aid and medical products and cutting tools. Its main products are first aid kits and medical supplies, scissors, shears, knives and sharpening tools. They are used in schools, homes, offices, hardware and sporting goods stores and industry.

It sells mainly to mass market and online retailers, industrial distributors, stationery distributors, office supply superstores, sporting goods stores and hardware chains, and also directly to consumers on its own websites. Net sales in 2025 were $196.5 million, and first aid and medical products are about 66% of total sales. Two customers each accounted for about 13% of net sales.

The company has operations in the United States, Canada, Germany, Hong Kong and China. It buys most of its products from suppliers outside the United States, mainly in Asia, and assembles first aid kits at plants in North America. It names Honeywell and Cintas as main competitors in first aid and safety, and 3M and Fiskars in cutting. It had 649 employees at the end of 2025.

Its biggest risks, as it describes them

  • Losing a major customer, since two customers each account for a large share of its sales.
  • Tariffs on goods it imports, mostly from Asia, and rising costs it cannot always pass on in prices.
  • Trouble getting products to customers on time through shipping and fulfillment delays.
  • Difficulty forecasting sales and orders, which depend on demand it cannot easily predict.
  • It may need to raise more money to run the business.
From Acme United's annual report on Form 10-K, filed March 11, 2026, in our words; the 10-K has the full description and every risk factor. Updated with each new annual report.

Income statement

Revenue and net income
US$ billions, fiscal years; net losses in red. Revenue on the left axis, net income on the right; zero is the same line on both.
Revenue (left axis)Net income (right axis)
Gross profit, R&D and operating income
US$ billions, fiscal years. Gross profit is revenue minus the cost of what was sold; research and development is one of the costs paid from it; what remains after all operating costs is operating income. Losses in red.
Gross profitResearch and developmentOperating income
Margins
Percent of revenue
GrossOperatingNetFree cash flow

From fiscal 2016 to 2025, earnings per share grew 4.7% a year and net income 6.3% a year, as new shares raised the share count by 14% and diluted each share's earnings.

Diluted earnings per share
US$ per share, fiscal years, restated for any stock splits; loss years in red.

Returns on capital

Return on capital and on equity
Percent. Return on capital is after-tax operating income over the money invested in the business (debt plus equity, minus cash); return on equity is net income over shareholders' equity. Both use the average of opening and closing balances.
Return on capitalReturn on equity

Balance sheet

Cash and debt
US$ billions, at each fiscal year end. Debt includes finance leases.
Cash and short-term investmentsDebt
Assets, liabilities and equity
US$ billions, at each fiscal year end. Assets equal liabilities plus equity; negative equity in red.
Total assetsTotal liabilitiesShareholders' equity
Debt and liquidity ratios
Times. Debt to equity, current assets over current liabilities, and net debt over EBITDA (a full year's).
Debt to equityCurrent ratioNet debt to EBITDA

Five years at a glance

Fiscal year endFY21FY22FY23FY24FY25
Cash and short-term investments56564
Debt incl. finance leases3350131812
Net debt (negative means net cash)28448118
Net debt to EBITDA1.7x4.0x0.5x0.6x0.4x
Debt to equity0.4x0.6x0.1x0.2x0.1x
Interest coverage13.8x2.6x4.3x6.8x8.8x
Current ratio4.7x4.8x3.5x4.2x4.2x
Quick ratio2.1x1.9x1.4x1.7x1.6x
US$ millions unless stated, at each fiscal year end. Net debt to EBITDA is debt minus cash, divided by operating income before depreciation and amortization: roughly how many years of those earnings the net debt equals. Debt to equity is debt as a multiple of shareholders' equity. Interest coverage is operating income divided by interest expense. The current ratio is current assets over current liabilities; the quick ratio leaves out inventory.

Cash flow

Cash from operations, capital spending and free cash flow
US$ billions, fiscal years. Free cash flow is cash from operations minus capital spending; negative years in red.
Cash from operationsCapital spendingFree cash flow
Stock-based compensation and buybacks
US$ billions, fiscal years. Shares paid to employees (stock-based compensation, a cost that uses no cash) against cash spent buying shares back. Buybacks that only match it leave the share count roughly where it was.
Stock-based compensationShare buybacks
Dividends and buybacks
US$ billions, cash paid in each fiscal year
DividendsShare buybacks
Diluted share count
Weighted-average diluted shares, millions

Projections

Project Acme United's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.

What Acme United says to expect

  • Annual savings from closing the DMT plant in 2027The annual savings from the closure are expected to be more than $1.0 million in 2027.
The company's own words, from its earnings release (Form 8-K, Exhibit 99), filed October 27, 2026. They are its expectations, not ours, and not a forecast or price target from The Filing Desk. Replaced when the next release is out.

Insider trades

Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Acme United shares on the open market, and 3 insiders sold $1.7 million.

Buys and sells by month
US$ millions, open-market purchases (up) and sales (down) by officers, directors and 10% owners in each month.
BoughtSold
DateInsiderTradeSharesPriceValueFiling
Aug 18, 2026Brian S OlschanPresident and COO, DirectorSold7,308$61.48$449,312Form 4
Aug 13, 2026Brian BarkerDirectorSold3,821$60.50$231,170Form 4
Aug 12, 2026Brian S OlschanPresident and COO, DirectorSold339$58.39$19,794Form 4
Aug 11, 2026Brian S OlschanPresident and COO, DirectorSold159$57.99$9,220Form 4
Aug 10, 2026Brian S OlschanPresident and COO, DirectorSold5,304$57.07$302,699Form 4
Aug 10, 2026Rex Lynn DavidsonDirectorSold3,684$56.48$208,072Form 4
Aug 7, 2026Brian S OlschanPresident and COO, DirectorSold125$55.72$6,965Form 4
Aug 5, 2026Brian S OlschanPresident and COO, DirectorSold4,000$55.51$222,040Form 4
Aug 4, 2026Brian S OlschanPresident and COO, DirectorSold981$56.75$55,672Form 4
Aug 3, 2026Brian S OlschanPresident and COO, DirectorSold1$58.00$58Form 4
May 28, 2026Brian S OlschanPresident and COO, DirectorSold4,833$42.00$202,986Form 4
Open-market purchases and sales by officers, directors and 10% owners, from their Form 4 filings with the SEC: one row per person, day and filing, at the day's average price. Grants, option exercises and shares withheld for tax aren't counted. Insiders buy and sell for many reasons, such as taxes, spreading their savings or a plan set up months earlier, so a trade on its own says little about where a company is heading. For information only, not investment advice. Insider trades at all companies

Indicators

Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.

IndicatorFY23FY24FY25
Piotroski F-score7 of 96 of 97 of 9
Rule of 4011.4%4.0%4.9%
Altman Z''7.397.467.65
Accruals ratio−7.1%−1.2%−4.8%
Piotroski F-score: how many of nine simple tests of profitability, funding and efficiency the company passed in the year (Piotroski, 2000); 8 or 9 is strong, 0 to 2 weak. Rule of 40: revenue growth plus free cash flow margin; software investors treat 40% or more as the bar. Altman Z'': working capital, retained earnings, operating income and equity weighed against assets and liabilities (Altman, 1995); Altman puts above 2.6 in the safe zone and below 1.1 in the distress zone. Accruals ratio: net income minus cash from operations, over average total assets; lower means profit is backed by cash.

The nine F-score tests

TestFY23FY24FY25
Net income is positivePassPassPass
Cash from operations is positivePassPassPass
Return on assets rosePassFailFail
Cash from operations exceeds net incomePassPassPass
Debt fell relative to assetsPassFailPass
Current ratio roseFailPassPass
Share count didn't risePassFailPass
Gross margin rosePassPassPass
Revenue rose relative to assetsFailPassFail
F-score7 of 96 of 97 of 9
Companies that report no gross profit are scored on the other eight.

Compare

Put Acme United side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.

Similar companies

CompanyYearRevenue growthOperating marginFree cash flow marginReturn on capitalNet debt to EBITDAF-scoreCompare
Acme UnitedFY251.1%7.5%3.9%9.4%0.4x7
Kewaunee ScientificFY2617.3%5.9%5.2%14.3%0.5x4Compare
InterfaceFY255.4%11.8%8.8%19.0%0.6x7Compare
ACCO BrandsFY25−8.5%6.0%—5.6%4.7x7Compare
MSA SafetyFY253.7%19.8%15.8%17.3%0.9x6Compare
Each company's latest fiscal year. Fiscal years end in different months, so the periods don't line up exactly. Free cash flow margin is free cash flow as a share of revenue. Net debt to EBITDA is explained under the balance sheet, and the F-score under Indicators.

10 years of figures

Fiscal yearFY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Income statement
Revenue125131137142164182194192194196
Revenue growth13.4%4.8%5.2%3.7%15.1%11.0%6.5%−1.3%1.6%1.1%
Gross profit46485152606564727677
Research and development11110—————
Operating income888811136131415
Net income64568143181010
Diluted EPS (US$)1.641.091.301.602.313.450.824.862.452.49
Diluted shares (millions)4444444444
Cash flow
Cash from operations95415653291218
Capital expenditure23323645711
Free cash flow722133−1−12458
Dividends paid1122222222
Share buybacks1000020000
Acquisitions77000010112
Stock-based compensation0111122222
Balance sheet at fiscal year end
Cash and short-term investments6947456564
Debt incl. finance leases33444033393350131812
Total assets92115110111130144164149162171
Total liabilities46655755676785515553
Shareholders' equity4650525663777998107118
Margins and ratios
Gross margin36.6%36.7%36.9%36.5%36.3%35.6%32.8%37.7%39.3%39.4%
Operating margin6.8%6.0%5.4%5.9%7.0%7.0%3.2%6.9%7.3%7.5%
Net margin4.7%3.1%3.4%3.9%4.9%7.5%1.6%9.3%5.2%5.2%
Free cash flow margin5.7%1.3%1.2%9.1%1.9%−0.7%−0.7%12.7%2.5%3.9%
Rule of 40 (growth + FCF margin)19.1%6.1%6.4%12.9%17.1%10.3%5.8%11.4%4.0%4.9%
Return on capital9.4%6.3%7.2%8.3%10.5%11.3%4.6%9.0%10.3%9.4%
Return on equity13.1%8.4%9.0%10.2%13.7%19.5%3.9%20.1%9.8%9.1%
Return on assets6.8%3.9%4.1%5.0%6.7%10.0%2.0%11.3%6.4%6.1%
Net debt to EBITDA2.5x3.2x3.4x2.2x2.3x1.7x4.0x0.5x0.6x0.4x
US$ millions unless stated. Where a later 10-K restated a year, the latest filed figure is shown. Download all figures (CSV, US$ millions)
Source: Acme United's Form 10-K filings, from SEC EDGAR. For information only, not investment advice. The Filing Desk is not affiliated with Acme United.